Principle
The larger and more painful a commercial loss, the less likely an organisation is to examine it properly. This is precisely inverted from what a learning organisation would do, and the inversion is not accidental. It is what happens when the psychological cost of examination is borne by the people who control whether the examination occurs.
Behaviour
Small losses receive proportionate, if perfunctory, attention: a CRM field is filled in, a reason code selected, a manager perhaps mentions it in a one-to-one. Large losses, the strategic account that walked, the flagship deal that collapsed at the final stage, the competitive displacement in a lighthouse customer, generate a different response entirely. There is an initial burst of senior attention, frequently emotional, followed by a rapid organisational consensus about the cause, and then silence.
The consensus that forms in the first forty-eight hours almost always attributes the loss to an external factor: the competitor bought the deal, the buyer changed, procurement intervened, the market shifted. This consensus hardens quickly, gets repeated upward, and is never subsequently tested against evidence. The formal post-mortem, if one is scheduled at all, is frequently postponed, then quietly cancelled, because by the time it would occur everyone already knows what happened and revisiting it serves no one's interests.
Small losses get examined because nobody important is implicated. The more expensive the lesson, the less likely it is to be learned.
Evidence
Identify the five largest commercial losses of the trailing eighteen months. For each, establish whether a structured post-mortem was conducted, who conducted it, whether the customer was contacted independently, and whether any specific, assigned action resulted from it.
In most organisations, the answer for the largest losses is that no structured post-mortem occurred, or that one was conducted internally without customer input, or that it produced conclusions but no assigned owner or follow-up. Compare this against the treatment of the five largest wins, which are frequently examined in considerable detail and presented internally as case studies.
Where post-mortems did occur, examine whether the conclusion differed at all from the consensus that had formed in the first days after the loss. A post-mortem that merely ratifies the original explanation is not analysis. It is confirmation, and it will have surfaced nothing the organisation did not already believe.
Psychology
A large loss is a threat to the professional standing of everyone who touched it, and the more senior the people involved, the more powerful the incentive to establish an external cause quickly and move on. The rapid consensus about competitor pricing or buyer change is not a lie. It is a genuinely believed explanation that happens to be the least costly one available to the people forming it.
The organisational immune response to examining a large loss is therefore stronger, not weaker, than for a small one. Small losses can be examined because nobody important is implicated. The losses containing the most information are the ones the organisation is structurally least able to look at, and this asymmetry means that the more expensive the lesson, the less likely it is to be learned.
Commercial Risk
An organisation that does not examine its largest losses has no mechanism for improving the commercial behaviours that produced them, and those behaviours will recur. Worse, the unexamined external attribution becomes institutional truth, informing strategy, product roadmap, and competitive positioning on the basis of an explanation that was never tested against the customer's actual account of events.
For an acquirer, management's explanation of major historical losses should be treated as a hypothesis rather than a finding, and testing it directly with the lost customers is frequently one of the highest-yield diligence activities available. The gap between management's account and the customer's account, where it exists, is usually where the genuine, addressable commercial weakness sits.
The compounding risk is that competitive strategy gets built on this untested attribution. If a company believes for three years that it loses to a particular competitor on price, and the truth is that it loses on implementation credibility, then every pricing decision, every discount authorisation, and every competitive battlecard produced in those three years has been optimised against the wrong problem entirely, at considerable cumulative cost.
Investment Committee Note